PhiChem Corporation
300398.SZ · SHZ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | CN¥880 | CN¥762 | CN¥701 | CN¥747 |
| % Growth | 15.5% | 8.7% | -6.2% | – |
| Cost of Goods Sold | CN¥561 | CN¥480 | CN¥455 | CN¥518 |
| Gross Profit | CN¥319 | CN¥282 | CN¥246 | CN¥229 |
| % Margin | 36.3% | 37% | 35.1% | 30.6% |
| R&D Expenses | CN¥53 | CN¥50 | CN¥41 | CN¥50 |
| G&A Expenses | CN¥0 | CN¥66 | CN¥63 | CN¥66 |
| SG&A Expenses | CN¥131 | CN¥104 | CN¥102 | CN¥105 |
| Sales & Mktg Exp. | CN¥0 | CN¥39 | CN¥39 | CN¥39 |
| Other Operating Expenses | CN¥12 | CN¥12 | -CN¥49 | CN¥23 |
| Operating Expenses | CN¥196 | CN¥167 | CN¥93 | CN¥178 |
| Operating Income | CN¥123 | CN¥115 | CN¥153 | CN¥50 |
| % Margin | 14% | 15.1% | 21.8% | 6.7% |
| Other Income/Exp. Net | -CN¥20 | -CN¥5 | -CN¥0 | -CN¥2 |
| Pre-Tax Income | CN¥104 | CN¥110 | CN¥153 | CN¥48 |
| Tax Expense | CN¥20 | CN¥8 | CN¥28 | CN¥3 |
| Net Income | CN¥74 | CN¥97 | CN¥120 | CN¥41 |
| % Margin | 8.4% | 12.7% | 17.1% | 5.5% |
| EPS | 0.13 | 0.19 | 0.23 | 0.078 |
| % Growth | -31.6% | -17.4% | 194.9% | – |
| EPS Diluted | 0.13 | 0.19 | 0.23 | 0.078 |
| Weighted Avg Shares Out | 567 | 521 | 521 | 523 |
| Weighted Avg Shares Out Dil | 567 | 521 | 521 | 523 |
| Supplemental Information | – | – | – | – |
| Interest Income | CN¥4 | CN¥3 | CN¥2 | CN¥7 |
| Interest Expense | CN¥6 | CN¥9 | CN¥11 | CN¥4 |
| Depreciation & Amortization | CN¥0 | CN¥51 | CN¥53 | CN¥46 |
| EBITDA | CN¥110 | CN¥172 | CN¥217 | CN¥105 |
| % Margin | 12.5% | 22.6% | 31% | 14% |